NCBiotech News

Catalent, a major CDMO with two key facilities in North Carolina, says will invest up to $40 million to add a third -- a Durham County campus that will create 201 jobs upon completion.

Lusaris Therapeutics has announced plans to set up shop in RTP with $60 million in hand to develop its naturally derived and fast-acting psychedelic compound for treatment-resistant depression and other debilitating neuropsychiatric disorders.

The European Society of Gene and Cell Therapy has recognized North Carolina gene therapy pioneer and entrepreneur Jude Samulski, Ph.D., with its inaugural Founders Award.

The newly published analysis "Evidence & Opportunity 2022: Impact of Life Sciences in NC" documents why North Carolina continues to garner global admiration in the field.

Former Elo Life Systems CEO Fayaz Khazi, Ph.D., has launched a new digital biology company called Traitology, an amalgamation of technology for improving plant traits that improve yields, extend growing seasons, and make crops resilient to climate change and disease.

Believer Meats, an Israeli company that is commercializing cultivated meat made from animal cells, has announced plans to build a $123 million, 200,000-square-foot manufacturing facility in Wilson that will employ 100 people when fully operational three years from now.

Durham's HemoSonics has received an FDA OK to use its blood analyzer system in trauma and liver transplantation procedures.

Durham's Deep Blue Medical Advances has just gotten an FDA go-ahead to expand the market for its unique T-Line Hernia Mesh product.

NC startups FleurirABX, RAIN Scientific, Locus Biosciences and Resilient Biotics are developing technologies to address antibiotic resistance -- a growing global crisis with tremendous public health implications.

Enzyvant and Altavant, wholly owned subsidiaries of Sumitovant Biopharma, are forming a Triangle-based rare-disease biopharma company.

Zymtronix, a startup biotech with operations in RTP and Ithaca, N.Y., has named Adam Monroe as president and COO.

Durham medical device and diagnostics company Baebies has received FDA permission to market a rapid, point-of-care test for the world’s most common enzyme deficiency.

The Joint School of Nanoscience and Nanoengineering in Greensboro is partnering with the U.S. Army Combat Capabilities Development Command (DEVCOM) Soldier Center to create a new research initiative called ICONS.

FUJIFILM Corporation is investing $188 million in a cell culture media manufacturing facility in Research Triangle Park, adding more than 100 new jobs.

Triangle's big three research universities, NCBiotech sponsor Venture Day to put early-stage life sciences spinouts together with investors.